| scholarly article | Q13442814 |
| P50 | author | Fatemeh Farshadpour | Q56654446 |
| Manoochehr Makvandi | Q56654447 | ||
| Reza Taherkhani | Q42847519 | ||
| P2860 | cites work | Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE). | Q47356311 |
| Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. | Q53751408 | ||
| High Mortality Associated with an Outbreak of Hepatitis E among Displaced Persons in Darfur, Sudan | Q56830163 | ||
| Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes | Q72641895 | ||
| Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes | Q77320341 | ||
| Codon optimizer: a freeware tool for codon optimization | Q79149447 | ||
| The Synthetic Gene Designer: a flexible web platform to explore sequence manipulation for heterologous expression | Q82077449 | ||
| The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications | Q24498207 | ||
| In silico design of functional DNA constructs | Q30104573 | ||
| Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome | Q33415661 | ||
| DNA vaccination strategies against infectious diseases | Q33781695 | ||
| The role of codon selection in regulation of translation efficiency deduced from synthetic libraries | Q33809938 | ||
| Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein | Q33849127 | ||
| Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences | Q34001848 | ||
| Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. | Q34009561 | ||
| Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus | Q34045644 | ||
| Hepatitis E: an overview and recent advances in vaccine research. | Q34334086 | ||
| Recombinant vaccines for hepatitis E. | Q34399421 | ||
| Codon-Optimized Expression and Purification of Truncated ORF2 Protein of Hepatitis E Virus in Escherichia coli | Q34437470 | ||
| Prevalence of Hepatitis E Virus among Adults in South-West of Iran | Q35823844 | ||
| Cytokine Profiles and Cell Proliferation Responses to Truncated ORF2 Protein in Iranian Patients Recovered from Hepatitis E Infection | Q36103394 | ||
| Cooperation between CD4+ and CD8+ T cells: when, where, and how. | Q36427362 | ||
| Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus | Q37628823 | ||
| Toward the development of a hepatitis E vaccine | Q37881208 | ||
| Design and production of a multiepitope construct derived from hepatitis E virus capsid protein | Q39027960 | ||
| Cloning of fliC Gene From Salmonella typhimurium in the Expression Vector pVAX1 and Evaluation of its Expression in Eukaryotic Cells. | Q39505278 | ||
| Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay | Q40316613 | ||
| Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence | Q40500253 | ||
| OPTIMIZER: a web server for optimizing the codon usage of DNA sequences | Q41769919 | ||
| Gene optimization mechanisms: a multi-gene study reveals a high success rate of full-length human proteins expressed in Escherichia coli | Q42385485 | ||
| On relevance of codon usage to expression of synthetic and natural genes in Escherichia coli | Q42735667 | ||
| Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy | Q42982963 | ||
| Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Q43429538 | ||
| Hepatitis E virus superinfection in patients with chronic liver disease | Q44320311 | ||
| Effects of codon-optimization on protein expression by the human herpesvirus 6 and 7 U51 open reading frame | Q44551779 | ||
| Gene optimization leads to robust expression of human respiratory syncytial virus nucleoprotein and phosphoprotein in human cells and induction of humoral immunity in mice. | Q45384730 | ||
| Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice | Q45391069 | ||
| Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. | Q45400356 | ||
| A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus | Q45479898 | ||
| DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice | Q45763237 | ||
| GASCO: genetic algorithm simulation for codon optimization. | Q47290780 | ||
| P433 | issue | 12 | |
| P921 | main subject | hepatitis E | Q326643 |
| vector-borne disease | Q2083837 | ||
| hepatitis E virus | Q5731737 | ||
| P304 | page(s) | e26035 | |
| P577 | publication date | 2015-12-13 | |
| P1433 | published in | Jundishapur journal of microbiology JJM | Q26841997 |
| P1476 | title | Design, Construction and Cloning of Truncated ORF2 and tPAsp-PADRE-Truncated ORF2 Gene Cassette From Hepatitis E Virus in the pVAX1 Expression Vector | |
| P478 | volume | 8 |
| Q40084653 | A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine |
| Q37589024 | Designing, Construction and Expression of a Recombinant Fusion Protein Comprising the Hepatitis E Virus ORF2 and Rotavirus NSP4 in the Baculovirus Expression System |
| Q56588500 | Development of new hepatitis E vaccines |
| Q28072683 | Epidemiology of Hepatitis E in Pregnant Women and Children in Iran: A General Overview |
| Q26746193 | Epidemiology of hepatitis E virus in Iran |
| Q47117776 | Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines |
Search more.